| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3904530 | Urology | 2010 | 6 Pages |
Abstract
The measurements of 2 circulating biomarkers, TuM2-PK and TK1, in RCC patients before nephrectomy can be useful for predicting recurrence and stratifying the patients into risk groups for possible adjuvant treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Benjamin Nisman, Vladimir Yutkin, Hovav Nechushtan, Ofer N. Gofrit, Tamar Peretz, Simon Gronowitz, Dov Pode,